Quick Answer
Nuvation Bio Inc. reported Total Assets of $594.82 million for the year ending 2025.
- Nuvation Bio Inc. showed an increase of +10.0% in Total Assets from 2024 to 2025.
- This data is from Nuvation Bio Inc.'s annual report (Form 10-K), filed with the SEC on March 2, 2026.
- XBRL data for this metric is available from 2020 to 2025 (6 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q2 2020: $171.1 thousand | Q3 2020: $145.50 million | Q1 2021: $832.06 million | Q2 2021: $814.26 million | Q3 2021: $797.79 million | Q1 2022: $751.81 million | Q2 2022: $719.74 million | Q3 2022: $686.49 million | Q1 2023: $657.06 million | Q2 2023: $641.41 million | Q3 2023: $630.87 million | Q1 2024: $613.13 million | Q2 2024: $594.80 million | Q3 2024: $571.58 million | Q1 2025: $492.49 million | Q2 2025: $647.23 million | Q3 2025: $601.56 million.
- Over the full 6 years of available data (2020 to 2025), Nuvation Bio Inc.'s Total Assets has grown by 168.2%.
- Historical annual values: Fiscal year 2025: $594.82 million | Fiscal year 2024: $540.63 million | Fiscal year 2023: $621.48 million | Fiscal year 2022: $672.14 million | Fiscal year 2021: $776.15 million | Fiscal year 2020: $221.79 million.
- Data sourced from SEC EDGAR public filings as of August 5, 2026.
Last verified: